Skip to main content
MJH Life Sciences
  • Login
  • Register
  • Login
  • Register
Home
  • ONCOLOGY
  • News
  • Blogs
  • Topics
  • Hematology
  • Image IQ
  • Podcasts
  • Videos
  • Slideshows
  • Conferences
MJH Life Sciences

SUBSCRIBE: Print / eNewsletter

Practice & Policy

ASCO/AACR Experts Advocate for E-Cigarette Regulations

January 8, 2015
  • Anna Azvolinsky

Experts from ASCO and AACR have penned a statement for policymakers on the potential negative effects of e-cigarettes and other nicotine-deliveries electronics.

  • READ >>
  • Add new comment

Febrile Neutropenia Costly Problem in Metastatic Cancer

December 17, 2014
  • Leah Lawrence

Risk for febrile neutropenia was high among patients with metastases from a variety of common cancers and was associated with numerous clinical and economic consequences, including increased morbidity and mortality.

  • READ >>
  • Add new comment

What We Can Learn From Our Patients

December 16, 2014
  • David Eagle, MD
  • Bo Gamble

Patient satisfaction data can give practices insight into their operations and make specific, practice-level adjustments accordingly, and with aggregated data we can gain insights into global practice responsiveness and patient perceptions regarding care.

  • READ >>
  • Add new comment

Guide Helps Oncologists Fit Shared Decision-Making Into Everyday Practice

December 3, 2014
  • Janet Colwell

A panel of experts has put together a guide to implementing shared decision-making that provides tips for integrating the model into busy oncology practices.

  • READ >>
  • Add new comment

ASCO: Reform Medicaid to Improve Cancer Care for Low-Income Patients

November 20, 2014
  • Janet Colwell

ASCO is calling for major reforms to the Medicaid system in order to close gaps in cancer coverage and improve quality of care for low-income Americans.

  • READ >>
  • Add new comment

National Lung Screening Trial Limitations and Public Health Policy

November 15, 2014
  • Frederic W. Grannis, Jr, MD

NLST data clearly demonstrate that lung cancer screening is effective and safe and reduces lung cancer-specific mortality by at least 20%. There is no possible reason for CMS to further delay or restrict lung cancer screening for those at high risk.

  • READ >>
  • Add new comment

CT Lung Cancer Screening: Public Healthcare Policy and Guidelines Collide

November 15, 2014
  • Barry M. Straube, MD

The development of CT lung cancer screening, the publication of results from the NLST in 2011, and the grade-B recommendation for CT lung cancer screening in high-risk smokers by the USPSTF raise a number of interesting national health policy issues.

  • READ >>
  • Add new comment

The Time for Low-Dose Computed Tomography Screening Is Now: A Medical Oncologist Perspective

November 15, 2014
  • Benjamin P. Levy, MD
  • Daniel J. Becker, MD

The NLST is a landmark trial demonstrating that implementation of low-dose CT screening lowers lung cancer–related mortality. We must put the study results and cost-effectiveness analyses in the context of the staggering statistics: up to 65% of lung cancer patients present with advanced-stage disease where treatments are often costly, toxic, and only palliative in nature.

  • READ >>
  • Add new comment

Assumption of Risk, Healthcare Policy, and Cancer Screening

November 15, 2014
  • Nora Janjan, MD, MPSA, MBA

American medicine is poised for an expanded conflict over the assumption and consequences of risk in medical care.

  • READ >>
  • Add new comment

Medicare Will Cover Lung Cancer Screening

November 12, 2014
  • Dave Levitan

The Centers for Medicare & Medicaid Services announced plans to cover low-dose CT screening for lung cancer, based mainly on the National Lung Screening Trial.

  • READ >>
  • Add new comment

Pages

  • « first
  • ‹ previous
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • next ›
  • last »

Resource Topics rightRail

  • Resource Topics
  • Partner Content
  • Breast Cancer
  • Acute Myeloid Leukemia
  • HER2-Positive Breast Cancer
  • Videos Breast Cancer
  • Follicular Lymphoma
Cutaneous T-Cell Lymphomas: Mycosis Fungoides and Sézary Syndrome
3 Keys to Success in the Oncology Care Model

Current Issue

ONCOLOGY Vol 33 No 11
Nov 21, 2019 Vol 33 No 11
Subscribe
Connect with Us
  • Column 1
    • Home
    • About Us
    • Contact Us
  • Column 2
    • Editorial Info
    • Editorial Board
  • Column 3
    • Advertising Info
    • Reprints
    • Advertising Terms
  • Column 4
    • Terms of Use
    • Privacy Policy
Modern Medicine Network
© UBM 2019, All rights reserved.
Reproduction in whole or in part is prohibited.

We've noticed that you're using an ad blocker

Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.

It's off now Dismiss How do I disable my ad blocker?
❌

How to disable your ad blocker for our site:

Adblock / Adblock Plus
  • Click on the AdBlock / AdBlock Plus icon on the top right of your browser.
  • Click “Don’t run on pages on this domain.” OR “Enabled on this site.”
  • Close this help box and click "It's off now".
Firefox Tracking Prevention
  • If you are Private Browsing in Firefox, "Tracking Protection" may casue the adblock notice to show. It can be temporarily disabled by clicking the "shield" icon in the address bar.
  • Close this help box and click "It's off now".
Ghostery
  • Click the Ghostery icon on your browser.
  • In Ghostery versions < 6.0 click “Whitelist site.” in version 6.0 click “Trust site.”
  • Close this help box and click "It's off now".
uBlock / uBlock Origin
  • Click the uBlock / uBlock Origin icon on your browser.
  • Click the “power” button in the menu that appears to whitelist the current website
  • Close this help box and click "It's off now".